Header Logo

Connection

FAYE M JOHNSON to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications FAYE M JOHNSON has written about Drug Evaluation, Preclinical.
FAYE M JOHNSON
Connection Strength
0.136
Drug Evaluation, Preclinical
  1. Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutants. Cancer Lett. 2018 09 01; 431:64-72.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.